Therefore, our findings clearly indicate that the tumor suppressive role of NDRG2 may be in part due to its inhibitory effect on PD-L1 expression in tumor cells, and that it is intimately involved in directly controlling T cell activity in the tumor microenvironment. The gene discussed is CD274; the disease is neoplasm.